跳至主要内容
临床试验/NCT05919810
NCT05919810已完成不适用

The Effects of Oral Probiotics and Herbal Supplementation on the Gut Microbiome and Sebum Excretion Rate in Non-Cystic Acne

Integrative Skin Science and Research2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2023年7月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
36
试验地点
2
主要终点
Gut microbiome composition of short chain fatty acid producing bacteria

研究概览

简要总结

The purpose of this study is to evaluates how probiotics and dietary supplementation with an herbal powder can shift the gut microbiome in those with non-cystic acne vulgaris.

详细描述

The investigators hope to evaluate the effects of oral supplements in changing intestinal health and the gut bacteria in patients with non-cystic acne vulgaris.

Acne is a chronic inflammatory condition that is estimated to affect greater than 85% of the population at some point. While antibiotics are typically used for systemic therapy, it can increase the risk for drug-resistant bacteria and shift the gut microbiome in a negative way. On the other hand, probiotics and dietary supplementation have been shown to support the gut microbiome.

In this study, participants will be randomized to either receiving a probiotic or powder supplement.

This means that participants will have an equal chance of receiving either product as half of the participants will be randomized to receive only oral probiotic, and the other half will receive oral supplement powder.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
12 Years 至 45 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects 12 years of age until 45 years of age
  • The presence of mild to moderate acne based on investigator global assessment.
  • Presence of at least 10 inflammatory lesions and at least 5 non-inflammatory lesions

排除标准

  • The presence of severe acne as noted by the investigator global assessment.
  • Those who are unwilling to discontinue oral probiotic-based supplementation, or supplement ingredients found in the study's oral product 1 month prior to enrollment.
  • Those who are unwilling to discontinue topical antibiotics and topical benzoyl peroxide for 2 weeks prior to enrollment
  • Those who are unwilling to keep their facial regimen the same throughout the study
  • Individuals who have been on an oral antibiotic for acne within the previous one month.
  • Individuals who are pregnant or breastfeeding.
  • Individuals who have changed any of their hormonal based contraception or therapies within 3 months prior to joining the study.
  • Individuals on oral contraceptive pills or progesterone or estrogen containing therapies
  • Use of isotretinoin within the three months prior to enrollment.
  • Individuals on finasteride or dutasteride
  • Current tobacco smoker or a tobacco smoking history

结局指标

主要结局

Gut microbiome composition of short chain fatty acid producing bacteria

时间窗: 8 weeks

Change on the relative abundance of Akkermansia mucinaphila and Facelibacterium pruasntizii

Stool acetate levels

时间窗: 8 weeks

Assess the short chain fatty acid stool acetate levels

次要结局

  • Change in salivary progesterone levels(8 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验